Vauchier C, Pluvy J, Theou-Anton N, Soussi G, et al. Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting POLE mutation and deficient mismatch repair pathway. Lung Cancer 2021;160:28-31.
PMID: 34371300